UBS Group
HTGM

UBS Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,198
Closed -$14K 9125
2023
Q1
$14K Buy
5,198
+3,223
+163% +$8.7K ﹤0.01% 6276
2022
Q4
$7.88K Buy
1,975
+1,949
+7,496% +$7.78K ﹤0.01% 7655
2022
Q3
$0 Hold
26
﹤0.01% 10262
2022
Q2
$0 Sell
26
-3,974
-99% ﹤0.01% 10249
2022
Q1
$6K Buy
4,000
+1,762
+79% +$2.64K ﹤0.01% 8003
2021
Q4
$12K Sell
2,238
-470
-17% -$2.52K ﹤0.01% 7499
2021
Q3
$15K Buy
2,708
+2,649
+4,490% +$14.7K ﹤0.01% 6408
2021
Q2
$0 Buy
59
+33
+127% ﹤0.01% 8833
2021
Q1
$0 Sell
26
-4,558
-99% ﹤0.01% 8430
2020
Q4
$22K Buy
+4,584
New +$22K ﹤0.01% 5879
2020
Q3
Sell
-38,308
Closed -$27K 7560
2020
Q2
$27K Buy
38,308
+24,247
+172% +$17.1K ﹤0.01% 5514
2020
Q1
$4K Buy
14,061
+8,052
+134% +$2.29K ﹤0.01% 6510
2019
Q4
$4K Buy
6,009
+5,414
+910% +$3.6K ﹤0.01% 6619
2019
Q3
$0 Sell
595
-7,100
-92% ﹤0.01% 7261
2019
Q2
$13K Buy
7,695
+3,415
+80% +$5.77K ﹤0.01% 6040
2019
Q1
$10K Sell
4,280
-16,980
-80% -$39.7K ﹤0.01% 6001
2018
Q4
$54K Buy
21,260
+20,665
+3,473% +$52.5K ﹤0.01% 5133
2018
Q3
$3K Sell
595
-6,936
-92% -$35K ﹤0.01% 6755
2018
Q2
$25K Buy
7,531
+7,046
+1,453% +$23.4K ﹤0.01% 5631
2018
Q1
$2K Hold
485
﹤0.01% 6678
2017
Q4
$1K Sell
485
-3,039
-86% -$6.27K ﹤0.01% 6764
2017
Q3
$6K Buy
3,524
+2,469
+234% +$4.2K ﹤0.01% 6249
2017
Q2
$3K Sell
1,055
-18,718
-95% -$53.2K ﹤0.01% 6363
2017
Q1
$137K Buy
+19,773
New +$137K ﹤0.01% 4045
2016
Q4
Sell
-6,242
Closed -$14K 6967
2016
Q3
$14K Sell
6,242
-20,507
-77% -$46K ﹤0.01% 5664
2016
Q2
$73K Buy
+26,749
New +$73K ﹤0.01% 4408
2016
Q1
Sell
-5,935
Closed -$26K 6948
2015
Q4
$26K Buy
+5,935
New +$26K ﹤0.01% 5332
2015
Q3
Sell
-436
Closed -$5K 7004
2015
Q2
$5K Buy
+436
New +$5K ﹤0.01% 6304